EW vs ROP · P/E 47, rev $1.39B vs P/E 41, rev $1.88B
Edwards Lifesciences Corp (EW) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
EW currently screens at market cap $49.91B and trailing P/E 46.9. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the EW and ROP stock pages for the full models.
Not investment advice.